Clorox (NYSE:CLX) Price Target Lowered to $100.00 at Wells Fargo & Company

Key Points

• Wells Fargo cut its Clorox price target from $110 to $100 and kept an "equal weight" rating, with the new target implying roughly a 12.9% upside from the prior close.
• Q3 results showed an EPS beat ($1.64 vs. $1.55) while revenue was essentially flat at $1.67B, but management trimmed FY‑2026 EPS guidance (5.45–5.65), triggering a stock drop to $88.57 and a 52‑week low.
• Analyst sentiment is cautious: MarketBeat reports an average "Reduce" rating and a consensus target of $107.13, with the majority of brokers at Hold and several at Sell.

Clorox (NYSE:CLX - Get Free Report) had its price objective lowered by stock analysts at Wells Fargo & Company from $110.00 to $100.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has an "equal weight" rating on the stock. Wells Fargo & Company's price objective indicates a potential upside of 12.91% from the stock's previous close.

Other research analysts also recently issued reports about the stock. Rothschild & Co Redburn set a $117.00 price target on shares of Clorox in a research note on Friday, February 13th. TD Cowen raised their target price on shares of Clorox from $98.00 to $111.00 and gave the stock a "hold" rating in a report on Tuesday, March 31st. Royal Bank Of Canada cut their target price on shares of Clorox from $132.00 to $127.00 and set a "sector perform" rating on the stock in a report on Thursday, April 9th. Barclays set a $85.00 target price on shares of Clorox in a report on Friday. Finally, Wall Street Zen upgraded shares of Clorox from a "sell" rating to a "hold" rating in a report on Saturday, February 7th. One equities research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Reduce" and a consensus target price of $107.13.

Clorox Price Performance

Shares of CLX stock traded down $7.88 during trading hours on Friday, hitting $88.57. 1,809,935 shares of the company's stock were exchanged, compared to its average volume of 2,302,860. The company has a market capitalization of $10.71 billion, a PE ratio of 14.49, a PEG ratio of 0.47 and a beta of 0.65. Clorox has a 12-month low of $86.79 and a 12-month high of $140.24. The business's 50 day simple moving average is $108.21 and its 200-day simple moving average is $108.82. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The business's revenue was up .1% compared to the same quarter last year. During the same period last year, the firm posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts anticipate that Clorox will post 5.87 earnings per share for the current year.

Institutional Trading of Clorox

Several large investors have recently added to or reduced their stakes in the stock. Sequoia Financial Advisors LLC boosted its holdings in Clorox by 6.8% in the first quarter. Sequoia Financial Advisors LLC now owns 6,433 shares of the company's stock valued at $667,000 after acquiring an additional 411 shares in the last quarter. KLCM Advisors Inc. boosted its holdings in Clorox by 43.4% in the first quarter. KLCM Advisors Inc. now owns 18,230 shares of the company's stock valued at $1,889,000 after acquiring an additional 5,515 shares in the last quarter. Kornitzer Capital Management Inc. KS boosted its holdings in Clorox by 2.1% in the first quarter. Kornitzer Capital Management Inc. KS now owns 199,915 shares of the company's stock valued at $20,717,000 after acquiring an additional 4,102 shares in the last quarter. Main Street Research LLC boosted its holdings in Clorox by 4.5% in the first quarter. Main Street Research LLC now owns 9,537 shares of the company's stock valued at $988,000 after acquiring an additional 412 shares in the last quarter. Finally, Kestra Advisory Services LLC lifted its position in Clorox by 15.4% during the first quarter. Kestra Advisory Services LLC now owns 31,820 shares of the company's stock valued at $3,297,000 after buying an additional 4,252 shares during the period. Institutional investors own 78.53% of the company's stock.

Clorox News Roundup

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Q3 earnings beat consensus: Clorox reported non‑GAAP EPS of $1.64 versus estimates (~$1.55), which reassures investors on near‑term profit resilience. Clorox (CLX) Beats Q3 Earnings and Revenue Estimates
• Positive Sentiment: Management highlights growth initiatives: The earnings call stressed product innovation and targeted acquisitions as levers to restore top‑line growth and margins over time — a constructive long‑term message for investors. Clorox Co (CLX) Q3 2026 Earnings Call Highlights: Navigating Challenges with Strategic Innovations
• Neutral Sentiment: Revenue essentially flat and in line with expectations: Q3 sales were about $1.67B, roughly flat year‑over‑year and roughly matching street estimates, which explains the mixed market reaction (beat on EPS, matched on revenue). Clorox Reports Q3 Fiscal Year 2026 Results, Updates Outlook
• Neutral Sentiment: Stock was an after‑hours mover: CLX was flagged among after‑hours movers after the print, indicating heightened trading and volatility as markets digest the mixed news. After-hours movers: AAPL, ROKU, RBLX, TEAM, SNDK, RDDT, TWLO, CLX, WDC
• Negative Sentiment: Full‑year EPS outlook trimmed: Management updated FY‑2026 guidance below prior expectations, which caps upside and explains investor caution despite the quarter's EPS beat. Clorox Posts Mixed Q3 Results, Lowers Fiscal 2026 Outlook
• Negative Sentiment: Weaker demand and rising costs cited: Reports note the company cut its profit forecast due to softer demand and cost pressures, two factors that weigh on margins and near‑term returns. Clorox cuts annual profit forecast on weaker demand, rising costs
• Negative Sentiment: Shares have recently hit 52‑week lows amid the mixed print and lowered outlook, signaling continued investor caution and possible technical selling pressure. Consumer Products Giant Clorox Shares Are Hitting New 52-Week Lows Thursday: Here's Why

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.